TNDM is currently covered by 15 analysts with average potential upside of $19.61 (27.42%) backed by 150 price targets and 172 ratings. Documented since 09-Dec-2013. Analyst's average stock valuation to be materialised ratio is 68.01% with an average time for price targets to be met of 95 days.
Most recent stock forecast was given by JAYSON BEDFORD from RAYMOND JAMES on 24-Feb-2023.
Highest price target for TNDM is 141, Lowest price target is 36, average price target is 88.5.
Currently, out of the existing stock ratings of TNDM - 16 which are a Hold (26.67%), 42 which are a Buy (70%), 2 which are a Sell (3.33%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
47
$4.89 (11.61%)
52
1 months 3 days ago
6/10 (60%)
$12.63 (21.89%)
89
Hold
40
$-2.11 (-5.01%)
87
1 months 4 days ago
11/11 (100%)
$3.73 (13.29%)
90
Buy
50
$7.89 (18.74%)
70
1 months 4 days ago
14/20 (70%)
$20.02 (28.48%)
134
Buy
52
$9.89 (23.49%)
61
1 months 4 days ago
1/5 (20%)
$29.57 (47.79%)
83
Sell
43
$0.89 (2.11%)
49
4 months 12 days ago
6/9 (66.67%)
$17.53 (17.81%)
60
What is TNDM(Tandem Diabetes Care, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on TNDM(Tandem Diabetes Care, Inc) with a proven track record?
